sulfolipid i has been researched along with dinoprostone in 1 studies
Studies (sulfolipid i) | Trials (sulfolipid i) | Recent Studies (post-2010) (sulfolipid i) | Studies (dinoprostone) | Trials (dinoprostone) | Recent Studies (post-2010) (dinoprostone) |
---|---|---|---|---|---|
22 | 0 | 8 | 29,105 | 1,346 | 6,357 |
Protein | Taxonomy | sulfolipid i (IC50) | dinoprostone (IC50) |
---|---|---|---|
Prostaglandin E2 receptor EP1 subtype | Homo sapiens (human) | 0.0155 | |
Prostaglandin E2 receptor EP4 subtype | Homo sapiens (human) | 0.0031 | |
Prostaglandin E2 receptor EP4 subtype | Rattus norvegicus (Norway rat) | 0.0021 | |
Prostaglandin E2 receptor EP3 subtype | Homo sapiens (human) | 0.002 | |
Prostaglandin E2 receptor EP2 subtype | Homo sapiens (human) | 0.0087 | |
Prostacyclin receptor | Homo sapiens (human) | 0.26 | |
Prostaglandin E2 receptor EP2 subtype | Rattus norvegicus (Norway rat) | 0.0052 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brozna, JP; Goren, MB; Gross, JM; Pabst, MJ | 1 |
1 other study(ies) available for sulfolipid i and dinoprostone
Article | Year |
---|---|
Inhibition of macrophage priming by sulfatide from Mycobacterium tuberculosis.
Topics: Dinoprostone; Dose-Response Relationship, Immunologic; Glycolipids; Humans; Immunosuppressive Agents; Interferon-gamma; Kinetics; Lipopolysaccharides; Macrophage Activation; Membrane Lipids; Mycobacterium tuberculosis; Phagocytosis; Prostaglandins E; Superoxides; Virulence Factors | 1988 |